P32/98 hemifumarate

Research use only, not for human use.

P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.

P32/98 hemifumarateis a potent inhibitor of dipeptidyl peptidase IV with a Ki value of 130 nM. P32/98 hemifumarate improves glucose tolerance, insulin sensitivity and β-cell responsiveness in fatty Zucker rat model.

GLP-1 acts function of stimulation of glucose dependent insulin secretion and induction of satiety feelings, and DPPIV is the major renal catabolic pathway for GLP-1 in vivo.P32/98 hemifumarate, together with 200 pM GLP-1, (10 μM; 3 h) shows no significant inhibition of sodium re-absorption in porcine proximal tubular cells.P32/98 hemifumarate (10 μM; 96 h) does not influence the mRNA expression of GLP-1R, DPPIV, Na+/H+ exchanger isoform 3 (NHE3), sodium-dependent glucose transporter slc5a1, slc5a2 (SGLT1, 2).Cell Cytotoxicity Assay Cell Line:Porcine proximal tubular cells Concentration:10 μM Incubation Time:96 hours Result:Showed no toxic.

P32/98 hemifumarate (25 mg/kg; i.g.; once daily) long-time treatment significantly improves the glucose tolerance in Zucker diabetic fatty rats, a model of IGT (impaired glucose tolerance).Animal Model:Zucker diabetic fatty rat Dosage:25 mg/kg Administration:Oral gavage; once daily Result:Significantly improved the glucose tolerance in Zucker diabetic fatty rats.

——

Metabolic Enzyme/Protease

DPP

DPP-4

——

——

251572-86-8

520.71

C22H40N4O6S2

>98% (HPLC)

——

OC(/C=C/C(O)=O)=O.CC[C@H](C)[C@H](N)C(N1CCSC1)=O.CC[C@H](C)[C@H](N)C(N2CCSC2)=O

——

(-20℃)

With Ice Pack

≥ 2 years